PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease

European Journal of Dermatology

Volumn 18, Issue 6, 2008, Pages 667-670

  Ghoreschi, Kamran ^a   Thomas, Peter ^b   Penovici, Marius ^c   Ullmann, Johanna ^c   Sander, Christian A ^d   Ledderose, Georg ^c   Plewig, Gerd ^b   Kolb, Hans Jochem ^c   Röcken, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d Department of Dermatology ^*  (Germany)

Author keywords

Graft versus host disease; Phototherapy; Psoralen; Retinoid; Scleroderma; Ultraviolet A

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; ISOTRETINOIN; METHOTREXATE; METHOXSALEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; LOW DRUG DOSE; MALE; PATIENT SAFETY; PHOTOCHEMOTHERAPY; PHOTOSENSITIVITY; PLASMACYTOMA; PUVA; RADIATION DOSE; SCLERODERMA; SKIN ULCER; TREATMENT RESPONSE;

ADULT; BATHS; CHRONIC DISEASE; DERMATOLOGIC AGENTS; GRAFT VS HOST DISEASE; HUMANS; ISOTRETINOIN; METHOXSALEN; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PUVA THERAPY; SCLEROSIS; SKIN;

EID: 57749176631     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0517     Document Type: Article

References (23)

1. Vogelsang GB, Lee L, Bensen-Kennedy DM. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med 2003; 54: 29-52.
2. Aractingi S, Chosidow O. Cutaneous graft-versus-host disease. Arch Dermatol 1998; 134: 602-12.
3. Kerscher M, Volkenandt M, Meurer M, Lehmann P, Plewig G, Rocken M. Treatment of localised scleroderma with PUVA bath photochemotherapy. Lancet 1994; 343: 1233.
4. Kerscher M, Meurer M, Sander C, Volkenandt M, Lehmann P, Plewiq G, Rocken M. PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients. Arch Dermatol 1996; 132: 1280-2.
5. Lüftl M Degitz K, Plewi?, G, Röcken M. Psoralen bath plus UV-A therapy. Possizlities and limitations. Arch Dermatol 1997; 133: 1597-603.
6. Ghoreschi K, Röcken M. Phototherapy of sclerosing skin diseases. Dermatology 2002; 205: 219-20.
7. Röcken M, Ghoreschi K. Morphea and lichen sclerosus. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. 2nd ed. Elsevier London, 2008: 1469-83.
8. Furlong T, Leisenring W, Storb R, Anasetti C, Appelbaum FR, Carpenter PA, Deeg HJ, Doney K, Kiem HP, Nash RA, Sanders JE, Witherspoon R, Thompson D, Martin PJ. Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease. Biol Blood Marrow Transplant 2002; 8: 206-12.
9. Grundmann-Kollmann M, Martin H, Ludwig R, Klein S, Boehncke WH, Hoelzer D, Kaufmann R, Podda M. Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease. Transplantation 2002; 74: 1631-4.
10. Bonanomi S, Balduzzi A, Tagliabue A, Biagi E, Rovelli A, Corti P, Crippa D, Uderzo C. Bath PUVA thera y in pediatric patients with drug-resistant cutaneous graft-versus-host disease. Bone Marrow Transplant 2001; 28: 631-2.
11. Leiter U, Kaskel P, Krahn G, Gottlober P, Bunjes D, Peter RU, Kerscher M. Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease. Photodermatol Photoimmunol Photomed 2002; 18: 183-90.
12. Grundmann-Kollmann M, Behrens S, Gruss C, Gottlöber P, Peter RU, Kerscher M. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. J Am Acad Dermatol 2000; 42: 134-6.
13. Ständer H, Schiller M, Schwarz T. UVA1 therapy for sclerodermic graft-versus-host disease of the skin. J Am Acad Dermatol 2002; 46: 799-800.
14. Wetzig T, Sticherlinq M, Simon JC, Hegenbart U, Niederwieser D, Al-Ali HK. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin. Bone Marrow Transplant 2005; 35: 515-9.
15. Marcellus DC, Altomonte VL, Farmer ER, Horn TD, Freemer CS, Grant J, Vogelsang GB. Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease. Blood 1999; 93: 66-70.
16. Skert C, Patriarca F, Sperotto A, Cerno M, Fili C, Zaja F, Stocchi R, Geromin A, Damiani D, Fanin R. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome. Haematologica 2006; 91: 258-61.
17. White JM, Creamer D, du Vivier AW, Pagliuca A, Ho AY, Devereux S, Salisbury JR, Mufti GJ. Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges. Br J Dermatol 2007; 156: 1032-8.
18. Couriel DR, Hosing C, Saliba R, Shpall EJ, Anderlini P, Rhodes B, Smith V, Khouri I, Giralt S, de Lima M, Hsu Y, Ghosh S, Neumann J, Andersson B, Qazilbash M, Hymes S, Kim S, Champlin R, Donato M. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006; 107: 3074-80.
19. Schariffetter K, Wlaschek M, Hogg A, Bolsen K, Schothorst A, Goerz G Krieg T, Plewig G. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991; 283: 506-11.
20. Gruss C, Reed JA, Altmeyer P, McNutt NS, Kerscher M. Induction of interstitial collagenose (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997; 350: 1295-6.
21. Fisher GJ, Kong S. Phototherapy for scleroderma: biologic rationale, results, and promise. Curr Opin Rheumatol 2002; 14: 723-6.
22. Schlossberg H, Klumpp T, Sabol P, Herman J, Manqan K. Severe cutaneous ulceration following treatment with thalidomide for GVHD. Bone Marrow Transplant 2001; 27: 229-30.
23. Giaccone L, Martin P, Carpenter P, Moravec C, Hooper H, Funke VA, Storb R, Flowers ME. Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease. Bone Marrow Transplant 2005; 36: 337-41.